31Indexed trials
Market Rank #46 · Evidence Tier A
Malaysia
Neuroscience Intelligence
Malaysia neuroscience intelligence: 31 indexed trials, 11 institutions, research score 24.54.
7Recruiting
11Research institutions
24.5Research score
Evidence profile
20Sponsors
9Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 25 · ML priority 25 · Confidence 100 · Evidence 24.5
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons10trials
epilepsy5trials
stroke3trials
alzheimers2trials
dementia_other2trials
depression2trials
schizophrenia1trials
other_neurology1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC7trials
Bayer2trials
AbbVie2trials
Boehringer Ingelheim2trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2trials
University of Malaya2trials
Eidos Therapeutics, a BridgeBio company1trials
GlaxoSmithKline1trials
Janssen Research & Development, LLC1trials
Astellas Pharma Inc1trials